Trxade Group Announces Launch of Bonum+ B2B Platform
Bonum+ Bundles Telehealth, a COVID-19 Risk Assessment Tool and a PPE Purchasing Tool, through a Secure Mobile Dashboard for Corporate […]
Arcturus Therapeutics Announces that it has Initiated Dosing of its COVID-19 STARR™ mRNA Vaccine Candidate, LUNAR-COV19 (ARCT-021) in a Phase 1/2 study
Potential for highly differentiated COVID-19 vaccine profile with a single administration, at a low doseClinical study data expected in Q4 […]
Iterum Therapeutics Commences Rights Offering
DUBLIN, Ireland and CHICAGO, Aug. 11, 2020 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical […]
Lincoln Generates Double-Digit Student Start Growth, Higher Earnings and Positive Cash Flow from Operations During Second Quarter of 2020
WEST ORANGE, N.J., Aug. 11, 2020 (GLOBE NEWSWIRE) — Lincoln Educational Services Corporation (Nasdaq: LINC) today reported operating and financial […]
Akers Biosciences Announces $6.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Thorofare, New Jersey, Aug. 11, 2020 (GLOBE NEWSWIRE) — Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), today announced that it […]
BeyondSpring Initiates Expanded Access Program with Plinabulin for Patients Suffering from CIN in the U.S.
– NCCN Guideline Updates Highlight Need for Maximum CIN Prevention and Resource Allocation for COVID-19 Patients –– First Patient Dosed […]
SurveyMonkey Launches Tech Partner Program
SAN MATEO, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) — SurveyMonkey (Nasdaq: SVMK), a leader in agile software solutions for customer […]
Middlefield Banc Corp. Announces 2020 Third Quarter Cash Dividend Payment
MIDDLEFIELD, Ohio, Aug. 11, 2020 (GLOBE NEWSWIRE) — Middlefield Banc Corp. (NASDAQ: MBCN) today announced that the Company’s Board of […]
Black Diamond Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
CAMBRIDGE, Mass. and NEW YORK, Aug. 11, 2020 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology […]
BridgeBio Pharma, Inc. Reports Second Quarter 2020 Financial Results and Business Update
-Initiated four clinical trials, progressed its additional 11 ongoing clinical trials and submitted three INDs to FDA since the beginning […]
